Pharmacokinetics of a Recombinant Modified Amino Terminal Fragment of Bactericidal/Permeability‐Increasing Protein (rBPI<sub>21</sub>) in Healthy Volunteers
Robert J. Bauer(XOMA (United States)), Stephen F. Carroll(IGM Biosciences (United States)), Albert Cohen, N. Havrilla(University of Arizona), Nancy Wedel(XOMA (United States)), Mark White(Beatson West of Scotland Cancer Centre)
Cited by 8
Related Papers
Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock
|The Journal of Infectious Diseases|1999|611
Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.
|Proceedings of the National Academy of Sciences|1986|518
Crystal Structure of Human BPI and Two Bound Phospholipids at 2.4 Angstrom Resolution
|Science|1997|360
Structure, Function, and Therapeutic Use of IgM Antibodies
|Antibodies|2020|257